Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation

Key Points

Key points are not available for this paper at this time.

Abstract

The TP53 mutation, a prevalent tumor suppressor gene alteration, is linked to chemotherapy resistance, increased relapse rates and diminished overall survival (OS) in acute myeloid leukemia (AML) patients.

Read Full Paperexternally

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Journals

Hematology

Institutions

Shanghai Jiao Tong University

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.